Science Explorer Back to mapMap

Most cited papers from Fondazione Ricerca Molinette

What are the most cited papers from Fondazione Ricerca Molinette?

The most cited paper from Fondazione Ricerca Molinette is "Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis" (Vincenzo Mazzaferro et al., 2008), with 2,060 citations. Next come "European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update" (1,344) and "Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group" (1,219).

Showing 50 of 60 papers. Every paper with more than 187 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Vincenzo Mazzaferro et al. · The Lancet Oncology Open access 5 Dec 2008 2,060
2 European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update Marko M. Babjuk, Maximilian Burger, Éva Compérat et al. · European Urology 20 Aug 2019 1,344
3 Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group Hernán Trimarchi et al. · Kidney International Open access 22 Mar 2017 1,219
4 A proposed system for the nomenclature of hepatitis C viral genotypes Peter Simmonds et al. · Hepatology May 1994 1,024
5 EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin Samantha Cambier, Richard J Sylvester, Laurence Collette et al. · European Urology Open access 23 Jul 2015 660
6 A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) Guido Finazzi, Roberto Marchioli, Vincenzo Brancaccio et al. · Journal of Thrombosis and Haemostasis Open access 29 Apr 2005 590
7 Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data Gioacchino Leandro, Alessandra Mangia, Jason Minco Hui et al. · Gastroenterology Review May 2006 562
8 INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B Antonina Smedile, Giorgio Verme, Antonietta Cargnel et al. · The Lancet Oct 1982 536
9 Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance Jorg Reinier Oddens, Maurizio A. Brausi, Richard J Sylvester et al. · European Urology 2 Nov 2012 523
10 Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry Guido Finazzi, Vincenzo Brancaccio, Marco Moia et al. · The American Journal of Medicine May 1996 435
11 The Delta Agent Mario Rizzetto · Hepatology Sep 1983 423
12 Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial Bengt Fellström, Jonathan Barratt, H. Terence Cook et al. · The Lancet Open access 28 Mar 2017 414
13 Identification of the miR-106b ~ 25 MicroRNA Cluster as a Proto-Oncogenic PTEN -Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation Laura Poliseno, Leonardo Salmena, Luisa Riccardi et al. · Science Signaling Open access 13 Apr 2010 411
14 Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans Emanuela Arvat, Lidia Di Vito, Fabio Broglio et al. · Journal of Endocrinological Investigation Sep 2000 389
15 Induction of bilirubin clearance by the constitutive androstane receptor (CAR) Wendong Huang, Jun Zhang, Steven S. Chua et al. · Proceedings of the National Academy of Sciences Open access 18 Mar 2003 387
16 Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity Giampiero Muccioli, Matthias H. Tschöp, Mauro Papotti et al. · European Journal of Pharmacology Apr 2002 386
17 Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Maurizia Rossana Brunetto, Manuela Maria Giarin, Filippo Oliveri et al. · Proceedings of the National Academy of Sciences Open access 15 May 1991 383
18 Effect of a Lung Protective Strategy for Organ Donors on Eligibility and Availability of Lungs for Transplantation Luciana Mascia, Daniela Pasero, Arthur S. Slutsky et al. · JAMA Open access 14 Dec 2010 361
19 Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows Andrea Giustina et al. · Endocrine Reviews Open access 27 Apr 2024 348
20 Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study Luca Saverio Belli, Marina Berenguer, Paolo Angelo Cortesi et al. · Journal of Hepatology Open access 18 May 2016 345
21 Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe Ferruccio Bonino, Floriano Rosina, Mario Rizzetto et al. · Gastroenterology May 1986 336
22 Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial Antonio Palumbo · Blood 21 Jul 2004 332
23 Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial Luigi Dogliotti, Giacomo Cartenì, Salvatore Siena et al. · European Urology 2 Jan 2007 332
24 Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndromes Peiman Nazerian et al. · Circulation Open access 13 Oct 2017 320
25 A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy Mark Haas, Jacobien C. Verhave, Zhi-Hong Liu et al. · Journal of the American Society of Nephrology Open access 9 Sep 2016 315
26 T-lymphocyte response to hepatitis C virus in different clinical courses of infection Patrizia Botarelli, Maurizia Rossana Brunetto, M Minutello et al. · Gastroenterology Feb 1993 315
27 Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide Alessandra Larocca et al. · Blood 12 Aug 2011 289
28 Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial Maurizio Degiuli, Mitsuru Sasako, Marco Calgaro et al. · European Journal of Surgical Oncology Open access 23 Dec 2003 276
29 Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial C. Loguercio et al. · Free Radical Biology and Medicine Open access 14 Feb 2012 269
30 Chronic hepatitis D: A vanishing disease? An Italian multicenter study Giovanni Battista Gaeta, Tommaso Stroffolini, Maria Chiaramonte et al. · Hepatology Oct 2000 269
31 Atlas of the muscle motor points for the lower limb: implications for electrical stimulation procedures and electrode positioning Alberto Botter, Gianmosè Oprandi, Fabio Lanfranco et al. · European Journal of Applied Physiology 27 Jul 2011 266
32 “Delirium Day”: a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool on behalf of the Italian Study Group on Delirium (ISGoD), Giuseppe Bellelli, Alessandro Morandi et al. · BMC Medicine Open access 18 Jul 2016 265
33 Defective Neurogenesis in Citron Kinase Knockout Mice by Altered Cytokinesis and Massive Apoptosis Ferdinando Di Cunto, Sara Imarisio, Emilio Hirsch et al. · Neuron Open access Oct 2000 258
34 Single vs multivessel treatment during primary angioplasty: results of the multicentre randomised HEpacoat™ for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study Di Mario Carlo, Mara Sansa, Flavio Airoldi et al. · International Journal of Cardiovascular Interventions 2004 255
35 Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey Enrico Maria Trecarichi, Livio Pagano, Anna Candoni et al. · Clinical Microbiology and Infection Open access 22 Dec 2014 250
36 Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours Geneviève Fourel, CHRISTIAN G. TREPO, Lydie Bougueleret et al. · Nature Sep 1990 250
37 Perioperative cardiovascular monitoring of high-risk patients: a consensus of 12 Jean‐Louis Vincent, Paolo P. Pelosi, Rupert M. Pearse et al. · Critical Care Open access 7 May 2015 247
38 Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients Paolo Gontero et al. · European Urology 16 Jul 2014 246
39 Corticosteroids can reverse severe imatinib-induced hepatotoxicity. Per Ljungman, Lena Perez-Bercoff, Jerker Jonsson et al. · PubMed Open access 2006 246
40 Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta Grazia Anna Niro, Alessia Ciancio, Giovanni Battista Gaeta et al. · Hepatology Open access 30 Aug 2006 243
41 Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey Michelle Marie O'Shaughnessy, Susan L. Hogan, Bawana D. Thompson et al. · Nephrology Dialysis Transplantation Open access 24 Apr 2017 242
42 Colonoscopy in inflammatory bowel disease Angelo Pera, P Bellando, Daniela Caldera et al. · Gastroenterology 1987 238
43 Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group Heinz Ludwig et al. · Blood Open access 12 Feb 2008 234
44 Hepatitis D: Thirty years after Mario Rizzetto · Journal of Hepatology Open access 5 Feb 2009 234
45 A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B Maurizia Rossana Brunetto, Marietta Stemler, Ferruccio Bonino et al. · Journal of Hepatology Mar 1990 230
46 Tumor-Associated Transforming Growth Factor-β and Interleukin-10 Contribute to a Systemic Th2 Immune Phenotype in Pancreatic Carcinoma Patients Graziella Bellone, Anna Turletti, Elisa Artusio et al. · American Journal Of Pathology Open access Aug 1999 227
47 Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis Giovanni Lodi, Rinaldo Pellicano, M Carrozzo · Oral Diseases ReviewOpen access 19 Apr 2010 224
48 Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis Alfredo Marzano, Mauro Salizzoni, Wilma Debernardi-Venon et al. · Journal of Hepatology Jun 2001 224
49 Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's disease R. Caprilli, A. Andreoli, Lucio Capurso et al. · Alimentary Pharmacology & Therapeutics Feb 1994 217
50 Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures Alessandro Repici, Mássimo Conio, Claudio De Angelis et al. · Gastrointestinal Endoscopy Oct 2004 215

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.